Accomplished Sales and Marketing Executive Joins OraSure Technologies Management Team
04 Gennaio 2011 - 12:00PM
OraSure Technologies, Inc. (Nasdaq:OSUR) announced today that Tony
Zezzo has joined the Company as its new Executive Vice President,
Marketing and Sales, effective January 3, 2011.
In this position, Zezzo will have overall responsibility for the
Company's global marketing and sales operations, which includes the
domestic and international sales teams for our infectious disease
and substance abuse businesses, marketing, and client
services/customer care. Zezzo will report to Douglas A. Michels,
OraSure's President and CEO.
Zezzo joins OraSure as an accomplished sales and marketing
executive with almost 30 years experience in the diagnostics
industry. He most recently served as Vice President, North America
Sales and Marketing at the Ortho-Clinical Diagnostics division of
Johnson & Johnson where he had responsibility for sales and
marketing in the United States and Canada.
"We are delighted that Tony has joined OraSure to lead our Sales
and Marketing teams," said Michels. "Tony brings a tremendous depth
of experience in the diagnostics business in both domestic and
international markets. He is a proven sales and marketing executive
who will ensure that we continue to build upon our leadership
position in the markets we serve."
Zezzo joined Johnson & Johnson in 1985 and held a series of
increasingly responsible positions covering both domestic and
international markets. At Ortho Diagnostic Systems, his
initial responsibilities focused on growing sales in Ortho's global
blood screening, and blood bank businesses. In 1994, he became
Executive Director, Johnson & Johnson Health Care Systems and
was responsible for leading Johnson & Johnson's sales and
marketing efforts in the managed care market. Zezzo returned
to Ortho Diagnostics as Executive Director, Marketing and Sales for
the AIDS/Hepatitis Division in 1996. In 1999, he assumed the role
of Vice President Sales and Marketing for all of Ortho's businesses
in the United States, Canada and Latin America.
Zezzo graduated from Grove City College. He belongs to the
American Association of Blood Banks and is a member of the board at
the National Blood Foundation.
About OraSure Technologies
OraSure Technologies develops, manufactures and markets oral
fluid specimen collection devices using proprietary oral fluid
technologies, diagnostic products including immunoassays and other
in vitro diagnostic tests, and other medical devices. These
products are sold in the United States as well as internationally
to various clinical laboratories, hospitals, clinics,
community-based organizations and other public health
organizations, distributors, government agencies, physicians'
offices, and commercial and industrial entities.
OraSure Technologies is the leading supplier of oral-fluid
testing solutions for drugs of abuse and for the detection of
antibodies to HIV.
For more information on the Company, please go to
www.orasure.com.
The OraSure Technologies, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=6440
CONTACT: OraSure Technologies, Inc.
Investor Contact:
Ronald H. Spair, Chief Financial Officer
610-882-1820
investorinfo@orasure.com
Zer0 to 5ive for OraSure Technologies
Media Contact:
Jennifer Moritz
917-748-4006
jmoritz@0to5.com
Grafico Azioni OraSure Technologies (NASDAQ:OSUR)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni OraSure Technologies (NASDAQ:OSUR)
Storico
Da Lug 2023 a Lug 2024